Tricor and Budesonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tricor (fenofibrate) and Budesonide (budesonide). Common drug interactions include fatigue among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Tricor and Budesonide. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

On Jul, 16, 2026

36 people who take Tricor and Budesonide together, and have interactions are studied.

Tricor and Budesonide drug interactions.

What are the common drug interactions of Tricor and Budesonide, by gender? *:

female:

Fatigue (feeling of tiredness)
Pneumonia
Pain
Headache (pain in head)
Myalgia (muscle pain)
Injection site haemorrhage (bleeding from injection site)
Injection site pain
Weight increased
Influenza like illness
Nephrolithiasis (calculi in the kidneys)

male:

Confusional state
Adverse reaction
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Malaise (a feeling of general discomfort or uneasiness)
Neuropathy peripheral (surface nerve damage)
Pyrexia (fever)
Rash
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Tricor and Budesonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Apathy
Crying
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Hypertension (high blood pressure)
Impaired work ability
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site haemorrhage (bleeding from injection site)
Lung disorder (lung disease)
Neoplasm malignant (cancer tumour)
Palpitations (feelings or sensations that your heart is pounding or racing)

40-49:

Hospitalisation
Hypoaesthesia (reduced sense of touch or sensation)
Ingrowing nail
Injection site extravasation (flow of (blood or lymph) from injection site)
International normalised ratio decreased
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Pain in extremity
Peripheral coldness
Plantar fasciitis (painful inflammatory process of the plantar fascia)

50-59:

Injection site pain
Abdominal discomfort
Headache (pain in head)
Injection site bruising
Injection site haemorrhage (bleeding from injection site)
Malaise (a feeling of general discomfort or uneasiness)
Abdominal pain
Arthralgia (joint pain)
Back pain
Body temperature increased

60+:

Fatigue (feeling of tiredness)
Pneumonia
Balance disorder
Blood pressure increased
Cardiac disorder
Cardiac failure
Chills (felling of cold)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 22.22%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 16.67%
Diabetes: 5 people, 13.89%
Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 11.11%
Cardiac Disorder: 4 people, 11.11%
Depression: 4 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.33%
Anaemia (lack of blood): 3 people, 8.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tricor and Budesonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously